Human African trypanosomiasis, also known as sleeping sickness, is a neglected disease,
and it continues to pose a major threat to 60 million people in 36 countries in sub‐Saharan …

The neurological complications of human African trypanosomiasis (HAT) in man caused by
the unicellular protozoan parasites Trypanosoma brucei gambiense and T. b. rhodesiense …

Control of human African trypanosomiasis (HAT) is dependent on accurate diagnosis and
treatment of infected patients. However, sensitivities of tests in routine use are unsatisfactory …

Objective To assess the safety and effectiveness of eflornithine as first line treatment for
human African trypanosomiasis. Design Cohort study. Setting Control programme in Ibba …

Human African trypanosomiasis is an infectious disease which has resulted in the deaths of
thousands of people in Sub-Saharan Africa. Two subspecies of the protozoan parasite …

The chemotherapeutic efficacy of diminazene aceturate (Berenil®)–a standard veterinary
trypanocide and pentamidine isethionate (PMI)–a human trypanocide was compared in …

Currently, the conventional diagnosis of human African trypanosomiasis (HAT) is by
microscopic demonstration of trypomastigotes in blood, lymph, and/or cerebrospinal fluid …

Background. To date, no biological marker for treatment outcome in human African
trypanosomiasis (HAT) has been described. The accuracy of biological markers for …

Efficient synthetic routes have been developed for the preparation of two new
polyazamacrocycles tagged with structural motifs recognised by the Trypanosoma brucei P2 …

A growing problem with drug resistance in Human African Trypanosomiasis has
necessitated the implementation of screening programmes to monitor for its spread. This …